John Strouse: Grateful for ASH’s Support and for the Privilege of Working with Charity Oyedeji
John Strouse, Associate Professor of Medicine at Duke University Medical Center, shared on LinkedIn:
“I am glad that ASH exists to support researchers through this time of unprecedented disruption to research and the healthcare in the United States and that I have the privilege of working with Charity Oyedeji!”
Quoting American Society of Hematology’s post:
“This past summer, the National Institutes of Health cut funding for a sickle cell disease initiative led by Charity Oyedeji, before it was complete. The Sickle Cell Disease (SCD) Functional Assessment Validation and Refinement (SILVR) Study and the SickleFit Exercise Program were focusing on physical capabilities and independence for patients with SCD. Beyond disrupting patient care, such funding cuts may also discourage researchers, particularly those from underrepresented backgrounds, from pursuing vital work in hematology and SCD research.
Learn more and help protect critical research in hematology here.”
Get the latest ASH updates on Hemostasis Today.
-
Oct 8, 2026, 13:35Manuel Monreal: Why IVC Filter Retrieval Matters for VTE Outcomes
-
Oct 8, 2026, 12:53Hellen Ishikawa-Ankerhold: PhD and Postdoctoral Positions in Advanced Microscopy and Immunothrombosis at LMU Munich
-
Oct 8, 2026, 12:45Pedro Perez: World Thrombosis Day 2026 – Raising Awareness of Women’s VTE Risk
-
Oct 8, 2026, 12:20Berrin Gunaydin: Functional Biomarkers of Iron Deficiency in Pregnancy
-
Oct 8, 2026, 11:45Wolfgang Miesbach: Milvexian After Acute Coronary Syndrome – What LIBREXIA ACS Found
-
Oct 8, 2026, 11:36John Erbey: Kidney Disfunction as a Cause of Anemia
-
Oct 8, 2026, 11:31Navneet Mishra: Sitosterolemia as an Under-Recognised Cause of Cytopenias
-
Oct 8, 2026, 11:06Houman Khosravani: Stroke and Thrombosis – Bridging Neurology and Hemostasis
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis